Axiom Investors’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-89,120
Closed -$2.47M 132
2025
Q3
$2.47M Sell
89,120
-142,458
-62% -$4.13M 0.02% 114
2025
Q2
$7.52M Sell
231,578
-130,037
-36% -$4.2M 0.06% 86
2025
Q1
$12.6M Buy
361,615
+190,417
+111% +$5.98M 0.12% 67
2024
Q4
$3.97M Buy
171,198
+26,903
+19% +$680K 0.03% 112
2024
Q3
$4.52M Sell
144,295
-33,720
-19% -$1.03M 0.04% 109
2024
Q2
$4.93M Sell
178,015
-66,635
-27% -$1.99M 0.04% 107
2024
Q1
$8.21M Sell
244,650
-149,475
-38% -$4.84M 0.07% 98
2023
Q4
$13.3M Buy
394,125
+230,650
+141% +$7.09M 0.13% 74
2023
Q3
$5.29M Buy
163,475
+71,750
+78% +$2.42M 0.08% 68
2023
Q2
$2.98M Sell
91,725
-96,435
-51% -$2.91M 0.04% 89
2023
Q1
$5.98M Sell
188,160
-96,830
-34% -$2.9M 0.1% 73
2022
Q4
$8.58M Buy
284,990
+55,930
+24% +$1.74M 0.17% 71
2022
Q3
$7.21M Buy
+229,060
New +$7.33M 0.15% 75
2014
Q3
Sell
-22,075
Closed -$736K 170
2014
Q2
$736K Hold
22,075
0.02% 145
2014
Q1
$616K Buy
+22,075
New +$682K 0.01% 145
2013
Q3
Sell
-45,950
Closed -$3.03M 148
2013
Q2
$3.03M Buy
+45,950
New +$2.58M 0.11% 81

Other funds holding OPCH

Axiom Investors's OPCH Position: Q4 2025 in Review

Axiom Investors sold out of Option Care Health (OPCH) in Q4 2025, closing a stake of 89,120 shares — an estimated $2.47M sold.

Axiom Investors first reported a position in OPCH in Q2 2013 and held it in 16 quarters. The position peaked at $13.3M in Q4 2023. 365 funds tracked by Wall St. Rank hold OPCH as of Q4 2025.

  • Axiom Investors reported no remaining Option Care Health position as of Q4 2025 after selling out during the quarter.
  • Axiom Investors sold 89,120 Option Care Health shares in Q4 2025, an estimated $2.47M.
  • Axiom Investors first reported a position in Option Care Health in Q2 2013 and held it in 16 quarters.
  • Axiom Investors's Option Care Health position peaked at $13.3M in Q4 2023.
  • 365 funds tracked by Wall St. Rank held Option Care Health as of Q4 2025.

Based on Axiom Investors's 13F filing for Q4 2025, filed 11 Feb 2026.